Endometrial Endometrioid Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Endometrioid Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma [Phase 2]
This Phase 2 trial investigates nivolumab with or without ipilimumab in mismatch repair–deficient (dMMR) recurrent endometrial cancer and is…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers [Phase 1, Phase 2]
Clinical trial update exploring addition of the AKT inhibitor ipatasertib to megestrol acetate for recurrent or metastatic endometrial cance…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
A clinical trial update notes a study on predicting recurrence in low-risk endometrial cancer patients with FIGO grade 1–2 endometrioid aden…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer [NA]
Update on a clinical trial evaluating PET/CT and lymph node mapping to detect lymph node metastasis in high-risk endometrial cancer patients…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer [Phase 3]
Phase 3 trial evaluating adding pembrolizumab to paclitaxel and carboplatin for stage III-IV or recurrent endometrial cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer [Phase 2]
This is a Phase 2 clinical trial evaluating tazemetostat for recurrent ovarian or endometrial cancers; the study is currently not recruiting…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of Onapristone and Anastrozole for refractory hormone receptor-positive endometrial cancer…
-
CLINICAL_TRIALS trial_result · 2020-03-06Clinical Trial Update: Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating copanlisib in persistent or recurrent endometrial cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial evaluating sunitinib malate in patients with recurrent or metastatic endometrial cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy [Phase 2]
This Phase 2 clinical trial investigates neoadjuvant Depot medroxyprogesterone acetate before hysterectomy to assess changes in glandular ce…